(Q34749535)

4 August 2017

title

Hydralazine, antinuclear antibodies, and the lupus syndrome (English)

1 reference

4 August 2017

1 reference

1 reference

6

Hughes GR

1 reference

4 August 2017

Mansilla-Tinoco R

1

1 reference

4 August 2017

Harland SJ

2

1 reference

4 August 2017

Ryan PJ

3

1 reference

4 August 2017

Bernstein RM

4

1 reference

4 August 2017

Dollery CT

5

1 reference

4 August 2017

Bulpitt CJ

7

1 reference

4 August 2017

Morgan A

8

1 reference

4 August 2017

Jones JM

9

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 March 1982

1 reference

4 August 2017

1 reference

4 August 2017

volume

284

1 reference

4 August 2017

issue

6320

1 reference

4 August 2017

page(s)

936-939

1 reference

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

An improved and simplified method of detecting the acetylator phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

Antinuclear antibodies following hydralazine toxicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1496454

The epidemiology of systemic lupus erythematosus

7 July 2018

1 reference

12 December 2020

Rheumatic and febrile syndrome during prolonged hydralazine treatment

1 reference

12 December 2020

Treatment of hypertension with propranolol and hydralazine

1 reference

12 December 2020

A quantitative immunochemical measure of the primary interaction between I BSA and antibody

1 reference

12 December 2020

Syndrome simulating collagen disease caused by hydralazine (Apresoline)

1 reference

12 December 2020

Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.284.6320.936

0 references

PMC publication ID

1496454

1 reference

4 August 2017

1 reference